The rationale of increasing the FVIII level to prevent major bleeding is supported by data published by analysis of 433 patients with moderate and mild hemophilia A. The study showed a decrease in bleeding episode by 18% for every 1% increase in factor VIII activity level (25). Here, F8 is linked to hemophilia A.